Beam Therapeutics, Inc. (BEAM)
23.92
+0.27
(+1.14%)
USD |
NASDAQ |
Oct 15, 10:53
Beam Therapeutics Total Long Term Debt (Quarterly) : 232.15M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 232.15M |
| March 31, 2026 | 236.04M |
| December 31, 2025 | 139.76M |
| September 30, 2025 | 138.73M |
| June 30, 2025 | 141.85M |
| March 31, 2025 | 144.92M |
| December 31, 2024 | 147.96M |
| September 30, 2024 | 149.13M |
| June 30, 2024 | 152.60M |
| March 31, 2024 | 155.94M |
| December 31, 2023 | 160.40M |
| September 30, 2023 | 162.02M |
| June 30, 2023 | 165.64M |
| March 31, 2023 | 167.70M |
| December 31, 2022 | 171.63M |
| September 30, 2022 | 168.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 168.16M |
| March 31, 2022 | 140.78M |
| December 31, 2021 | 140.10M |
| September 30, 2021 | 138.96M |
| June 30, 2021 | 139.16M |
| March 31, 2021 | 132.71M |
| December 31, 2020 | 103.43M |
| September 30, 2020 | 29.99M |
| June 30, 2020 | 31.49M |
| March 31, 2020 | 31.05M |
| December 31, 2019 | 26.90M |
| September 30, 2019 | 24.28M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Prime Medicine, Inc. | 103.51M |
| Intellia Therapeutics, Inc. | 50.07M |
| Twist Bioscience Corp. | 84.96M |
| Q32 Bio, Inc. | 4.561M |
| Sarepta Therapeutics, Inc. | 1.046B |